Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 2131472
PUBLISHER: BCC Research | PRODUCT CODE: 2131472
Global Vaccine Adjuvants Market
PUBLISHED:
PAGES: 124 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
This report provides an analysis of the global market for vaccine adjuvants. It focuses on the key driving trends and challenges. The study evaluates the competitive landscape, reviews key technological developments, and provides market estimates and forecasts through 2031.
Report Scope
This report provides an overview of the global vaccine adjuvants market. It includes global revenue ($ millions), with 2025 as the base year, estimates for 2026, and forecasts through 2031. The market is segmented by product type, disease type, vaccine type, route of administration, application, and region. Based on product type, vaccine adjuvants are categorized into particulate-based adjuvants, emulsion adjuvants, saponin-based adjuvants, Toll-like receptor (TLR) agonists, and other adjuvants. Based on disease type, the market is categorized into infectious diseases, cancer, and other diseases. The regions covered in this study include North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with a focus on major countries in each region.
The report highlights the key trends and challenges affecting the market, along with analysis and discussions regarding patents, clinical trials, and emerging technologies.
The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key companies in the global vaccine adjuvants market. A dedicated company profile section provides information on leading companies, including GSK Plc., CSL, Novavax, Croda International Plc., Dynavax Technologies Corp., Avanti Research, Desert King, InvivoGen, SEPPIC, and SPI Pharma.
Report Includes
- An analysis of the global markets for vaccine adjuvant compounds and systems used in human and veterinary vaccines production
- Analyses of the global market trends, with historic data from 2023 to 2025, estimates for 2026 and projections of CAGRs through 2031
- Estimates of the market size and revenue prospects for global market, accompanied by a market share analysis by product type, disease type, vaccine type, route of administration, application, and region
- Facts and figures pertaining to the market dynamics, recent technological advancements in diabetes management, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter's Five Forces model, as well as global supply chain analyses
- Review of emerging technologies, market applications, industry structure, and key initiatives in clinical sequencing
- Patent review, featuring key granted and published patents
- Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Profiles of the leading global companies
Product Code: PHM293A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of the Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Market Definition
- Different Categories of Vaccine Adjuvants
- Role of Adjuvants in Different Vaccine Types
- Future of Vaccine Adjuvants
- Porter's Five Forces Analysis
- Threat of New Entrants (Low)
- Bargaining Power of Buyers (High)
- Bargaining Power of Suppliers (Moderate)
- Threat of Substitutes (Low)
- Level of Competitiveness (Moderate)
- Macroeconomic Factors Analysis
- Economic Growth and Healthcare Spending
- Rising Prevalence of Infectious and Chronic Diseases
- Regulatory Factors
- Technological Developments
- Impact of U.S. Tariff Laws on the Vaccine Adjuvants Market
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Essential Role of Adjuvants in Modern Vaccine Platforms
- Expansion of Global Immunization Programs and Vaccine Coverage
- Rising Veterinary Vaccination and Livestock Disease-Control Needs
- Technological Developments in Next-Generation Adjuvants
- Market Restraints
- High Regulatory and Clinical Validation Requirements
- Side Effects and Toxicity of Adjuvants
- Supply Chain Constraints for Specialized Adjuvant Components
- Market Opportunities
- Development of Advanced Combination and Precision Adjuvant Systems
- Expansion of Therapeutic and Cancer Vaccine Development
- Growth in the Companion Animal Market
Chapter 4 Regulatory Landscape
- Overview
- Regulations and Standards by Select Country or Region
Chapter 5 Emerging Technologies and Patent Analysis
- Overview
- Emerging Technologies
- Development of Precision Combination Adjuvant Systems
- Scalable and Synthetic Production of Advanced Adjuvants
- Nanostructured and Lipid-Based Delivery Platforms with Integrated Immunostimulation
- Clinical Trial Analysis
- Key Takeaways
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
- Patent Analysis
- Key Takeaways
- Patents, by Year
- By Top Applicant
- By Top Owner
- By Jurisdiction
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Vaccine Adjuvants Market, by Product Type
- Key Takeaways
- Particulate-Based Adjuvants
- Emulsion Adjuvants
- Saponin-Based Adjuvants
- TLR Agonists
- Other Adjuvants
- Vaccine Adjuvants Market, by Disease Type
- Key Takeaways
- Infectious Diseases
- Cancer
- Other Diseases
- Vaccine Adjuvants Market, by Vaccine Type
- Key Takeaways
- Human Vaccines
- Veterinary Vaccines
- Vaccine Adjuvants Market, by Application
- Key Takeaways
- Commercial Applications
- Research Applications
- Vaccine Adjuvants Market, by Route of Administration
- Key Takeaways
- Intramuscular
- Subcutaneous
- Intradermal
- Other Routes of Administration
- Geographic Breakdown
- Vaccine Adjuvants Market, by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Landscape
- Global Market Shares of Leading Companies
- Strategic Analysis
Chapter 8 Appendix
- Research Methodology
- References
- Abbreviations
- Company Profiles
- AVANTI RESEARCH
- CRODA INTERNATIONAL PLC
- CSL
- DESERT KING
- DYNAVAX TECHNOLOGIES CORP.
- GSK PLC
- INVIVOGEN
- NOVAVAX
- SEPPIC
- SPI PHARMA
- A Few Emerging Start-ups/Market Disruptors
Product Code: PHM293A
List of Tables
- Summary Table : Global Market for Vaccine Adjuvants, by Region, Through 2031
- Table 1 : Key Limitations of Traditional Vaccine Adjuvants
- Table 2 : Advantages of Next-Generation Vaccine Adjuvants
- Table 3 : Categories of Vaccine Adjuvants and Their Mechanisms
- Table 4 : Role of Adjuvants in Different Vaccine Types
- Table 5 : Porter's Five Forces: Rating Scale
- Table 6 : U.S. Pet Ownership Statistics, Dogs and Cats, 2025
- Table 7 : Regulatory Landscape Governing Vaccine Adjuvants, by Country/Region
- Table 8 : Clinical Trials for Vaccine Adjuvants, by Type of Study, as of March 2026
- Table 9 : Clinical Trials for Vaccine Adjuvants, by Status, as of March 2026
- Table 10 : Clinical Trials for Vaccine Adjuvants, by Phase, as of March 2026
- Table 11 : Notable Patents, by Top Applicants, 2024-2025
- Table 12 : Patents, by Top Owner, 2024-2025
- Table 13 : Patents, by Jurisdiction, 2024-2025
- Table 14 : Global Market for Vaccine Adjuvants, by Product Type, Through 2031
- Table 15 : Global Vaccine Adjuvants Market for Particulate-Based Adjuvants, by Region, Through 2031
- Table 16 : Global Vaccine Adjuvants Market for Emulsion Adjuvants, by Region, Through 2031
- Table 17 : Global Vaccine Adjuvants Market for Saponin-Based Adjuvants, by Region, Through 2031
- Table 18 : Global Vaccine Adjuvants Market for TLR Agonists, by Region, Through 2031
- Table 19 : Global Vaccine Adjuvants Market for Other Adjuvants, by Region, Through 2031
- Table 20 : Global Market for Vaccine Adjuvants, by Disease Type, Through 2031
- Table 21 : Global Vaccine Adjuvants Market for Infectious Diseases, by Region, Through 2031
- Table 22 : Global Vaccine Adjuvants Market for Cancer, by Region, Through 2031
- Table 23 : Global Vaccine Adjuvants Market for Other Diseases, by Region, Through 2031
- Table 24 : Global Market for Vaccine Adjuvants, by Vaccine Type, Through 2031
- Table 25 : Global Vaccine Adjuvants Market for Human Vaccines, by Region, Through 2031
- Table 26 : Global Vaccine Adjuvants Market for Veterinary Vaccines, by Region, Through 2031
- Table 27 : Global Market for Vaccine Adjuvants, by Application, Through 2031
- Table 28 : Global Vaccine Adjuvants Market for Commercial Applications, by Region, Through 2031
- Table 29 : Global Vaccine Adjuvants Market for Research Applications, by Region, Through 2031
- Table 30 : Global Market for Vaccine Adjuvants, by Route of Administration, Through 2031
- Table 31 : Global Vaccine Adjuvants Market for Intramuscular Route of Administration, by Region, Through 2031
- Table 32 : Global Vaccine Adjuvants Market for Subcutaneous Route of Administration, by Region, Through 2031
- Table 33 : Global Vaccine Adjuvants Market for Intradermal Route of Administration, by Region, Through 2031
- Table 34 : Global Vaccine Adjuvants Market for Other Routes of Administration, by Region, Through 2031
- Table 35 : Global Market for Vaccine Adjuvants, by Region, Through 2031
- Table 36 : North American Market for Vaccine Adjuvants, by Country, Through 2031
- Table 37 : North American Market for Vaccine Adjuvants, by Product Type, Through 2031
- Table 38 : North American Market for Vaccine Adjuvants, by Disease Type, Through 2031
- Table 39 : North American Market for Vaccine Adjuvants, by Vaccine Type, Through 2031
- Table 40 : North American Market for Vaccine Adjuvants, by Route of Administration, Through 2031
- Table 41 : North American Market for Vaccine Adjuvants, by Application, Through 2031
- Table 42 : European Market for Vaccine Adjuvants, by Country, Through 2031
- Table 43 : European Market for Vaccine Adjuvants, by Product Type, Through 2031
- Table 44 : European Market for Vaccine Adjuvants, by Disease Type, Through 2031
- Table 45 : European Market for Vaccine Adjuvants, by Vaccine Type, Through 2031
- Table 46 : European Market for Vaccine Adjuvants, by Route of Administration, Through 2031
- Table 47 : European Market for Vaccine Adjuvants, by Application, Through 2031
- Table 48 : Asia-Pacific Market for Vaccine Adjuvants, by Country, Through 2031
- Table 49 : Asia-Pacific Market for Vaccine Adjuvants, by Product Type, Through 2031
- Table 50 : Asia-Pacific Market for Vaccine Adjuvants, by Disease Type, Through 2031
- Table 51 : Asia-Pacific Market for Vaccine Adjuvants, by Vaccine Type, Through 2031
- Table 52 : Asia-Pacific Market for Vaccine Adjuvants, by Route of Administration, Through 2031
- Table 53 : Asia-Pacific Market for Vaccine Adjuvants, by Application, Through 2031
- Table 54 : South American Market for Vaccine Adjuvants, by Country, Through 2031
- Table 55 : South American Market for Vaccine Adjuvants, by Product Type, Through 2031
- Table 56 : South American Market for Vaccine Adjuvants, by Disease Type, Through 2031
- Table 57 : South American Market for Vaccine Adjuvants, by Vaccine Type, Through 2031
- Table 58 : South American Market for Vaccine Adjuvants, by Route of Administration, Through 2031
- Table 59 : South American Market for Vaccine Adjuvants, by Application, Through 2031
- Table 60 : MEA Market for Vaccine Adjuvants, by Sub-region, Through 2031
- Table 61 : MEA Market for Vaccine Adjuvants, by Product Type, Through 2031
- Table 62 : MEA Market for Vaccine Adjuvants, by Disease Type, Through 2031
- Table 63 : MEA Market for Vaccine Adjuvants, by Vaccine Type, Through 2031
- Table 64 : MEA Market for Vaccine Adjuvants, by Route of Administration, Through 2031
- Table 65 : MEA Market for Vaccine Adjuvants, by Application, Through 2031
- Table 66 : Leading Providers of Vaccine Adjuvants, 2025
- Table 67 : Recent Developments in the Vaccine Adjuvants Market, January 2023-March 2026
- Table 68 : Abbreviations Used in the Report
- Table 69 : Avanti Research: Company Snapshot
- Table 70 : Avanti Research: Product Portfolio
- Table 71 : Avanti Research: News/Key Developments, 2025
- Table 72 : Croda International Plc: Company Snapshot
- Table 73 : Croda International Plc: Financial Performance, FY 2024 and 2025
- Table 74 : Croda International Plc: Product Portfolio
- Table 75 : Croda International Plc: News/Key Developments, 2023-2024
- Table 76 : CSL.: Company Snapshot
- Table 77 : CSL: Financial Performance, FY 2023 and 2024
- Table 78 : CSL: Product Portfolio
- Table 79 : CSL: News/Key Developments, 2024
- Table 80 : Desert King: Company Snapshot
- Table 81 : Desert King: Product Portfolio
- Table 82 : Desert King: News/Key Developments, 2025
- Table 83 : Dynavax Technologies Corp.: Company Snapshot
- Table 84 : Dynavax Technologies Corp.: Product Portfolio
- Table 85 : Dynavax Technologies Corp.: News/Key Developments, 2023-2026
- Table 86 : GSK plc: Company Snapshot
- Table 87 : GSK plc: Financial Performance, FY 2024 and 2025
- Table 88 : GSK plc: Product Portfolio
- Table 89 : GSK plc: News/Key Developments, 2023-2025
- Table 90 : InvivoGen: Company Snapshot
- Table 91 : InvivoGen: Product Portfolio
- Table 92 : InvivoGen: News/Key Developments, 2024
- Table 93 : Novavax: Company Snapshot
- Table 94 : Novavax: Financial Performance, FY 2024 and 2025
- Table 95 : Novavax: Product Portfolio
- Table 96 : Novavax: News/Key Developments, 2024-2026
- Table 97 : SEPPIC: Company Snapshot
- Table 98 : SEPPIC: Product Portfolio
- Table 99 : SEPPIC: News/Key Developments, 2025
- Table 100 : SPI PHARMA: Company Snapshot
- Table 101 : SPI PHARMA: Product Portfolio
- Table 102 : SPI PHARMA: News/Key Developments, 2024
- Table 103 : List of a Few Emerging Startups/Market Disruptors
List of Figures
- Summary Figure : Summary Figure: Global Market Shares for Vaccine Adjuvants, by Region, 2025
- Figure 1 : Porter's Five Forces Analysis: Vaccine Adjuvants Market
- Figure 2 : Market Dynamics of Vaccine Adjuvants
- Figure 3 : Emerging Technologies in the Vaccine Adjuvants Market
- Figure 4 : Patents Granted, by Year, 2024-2025
- Figure 5 : Global Market Shares for Vaccine Adjuvants, by Product Type, 2025
- Figure 6 : Global Vaccine Adjuvants Market Shares for Particulate-Based Adjuvants, by Region, 2025
- Figure 7 : Global Vaccine Adjuvants Market Shares for Emulsion Adjuvants, by Region, 2025
- Figure 8 : Global Vaccine Adjuvants Market Shares for Saponin-Based Adjuvants, by Region, 2025
- Figure 9 : Global Vaccine Adjuvants Market Shares for TLR Agonists, by Region, 2025
- Figure 10 : Global Vaccine Adjuvants Market Shares for Other Adjuvants, by Region, 2025
- Figure 11 : Global Market Shares for Vaccine Adjuvants, by Disease Type, 2025
- Figure 12 : Global Vaccine Adjuvants Market Shares for Infectious Diseases, by Region, 2025
- Figure 13 : Global Vaccine Adjuvants Market Shares for Cancer, by Region, 2025
- Figure 14 : Global Vaccine Adjuvants Market Shares for Other Diseases, by Region, 2025
- Figure 15 : Global Market Shares for Vaccine Adjuvants, by Vaccine Type, 2025
- Figure 16 : Global Vaccine Adjuvants Market Shares for Human Vaccines, by Region, 2025
- Figure 17 : Global Vaccine Adjuvants Market Shares for Veterinary Vaccines, by Region, 2025
- Figure 18 : Global Market Shares for Vaccine Adjuvants, by Application, 2025
- Figure 19 : Global Vaccine Adjuvants Market Shares for Commercial Applications, by Region, 2025
- Figure 20 : Global Vaccine Adjuvants Market Shares for Research Applications, by Region, 2025
- Figure 21 : Global Market Shares for Vaccine Adjuvants, by Route of Administration, 2025
- Figure 22 : Global Vaccine Adjuvants Market Shares for Intramuscular Route of Administration, by Region, 2025
- Figure 23 : Global Vaccine Adjuvants Market Shares for Subcutaneous Route of Administration, by Region, 2025
- Figure 24 : Global Vaccine Adjuvants Market Shares for Intradermal Route of Administration, by Region, 2025
- Figure 25 : Global Vaccine Adjuvants Market Shares for Other Routes of Administration, by Region, 2025
- Figure 26 : Global Market Shares for Vaccine Adjuvants, by Region, 2025
- Figure 27 : North American Market Shares for Vaccine Adjuvants, by Country, 2025
- Figure 28 : European Market Shares for Vaccine Adjuvants, by Country, 2025
- Figure 29 : Asia-Pacific Market Shares for Vaccine Adjuvants, by Country, 2025
- Figure 30 : South American Market Shares for Vaccine Adjuvants, by Country, 2025
- Figure 31 : MEA Market Shares for Vaccine Adjuvants, by Sub-region, 2025
- Figure 32 : Global Market Share Analysis for Vaccine Adjuvants, by Company, 2025
- Figure 33 : Croda International Plc: Revenue Shares, by Business Unit, FY 2025
- Figure 34 : Croda International Plc: Revenue Shares, by Region/Country, FY 2025
- Figure 35 : CSL: Revenue Shares, by Business Unit, FY 2024
- Figure 36 : CSL: Revenue Shares, by Region/Country, FY 2024
- Figure 37 : GSK plc: Revenue Shares, by Business Unit, FY 2025
- Figure 38 : GSK Plc: Revenue Shares, by Region/Country, FY 2025
- Figure 39 : Novavax: Revenue Shares, by Business Unit, FY 2025
- Figure 40 : Novavax: Revenue Shares, by Region/Country, FY 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.